Prostatic Acid Phosphatase (PAP) (Serial Monitor)
Use
The Prostatic Acid Phosphatase (PAP) test is used for long-term serial monitoring of patients. PAP is an enzyme produced by the prostate and is a useful marker for monitoring prostate cancer therapy. Elevated levels of PAP may indicate prostate cancer or other conditions. This test provides a color graphic summary report of the patient's PAP levels over time, allowing healthcare providers to assess the effectiveness of treatment courses and make informed decisions.
Special Instructions
Not provided.
Limitations
Results obtained with different assay methods may not be directly comparable. Test values should not be interpreted as definitive evidence of the presence or absence of malignant disease. The assay methods used can influence the quantitative results and detection capability across different platforms, thus consistent methodology is advised for reliable longitudinal assessment.
Methodology
Immunoassay (Immulite 2000 Immunochemiluminometric assay (ICMA))
Biomarkers
Prostatic Acid Phosphatase
Analyte
LOINC Codes
- 20420-6 - PACP Ser-mCnc
- 80563-0 - Report
Result Turnaround Time
4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
Other tests from different labs that may be relevant